Surgical Gonad Removal

Removing both gonads markedly reduces production of sex hormones because the tissues that produce those hormones are no longer present. The resulting endocrine change is substantially different from removing only one gonad. Follow-up therefore addresses hormonal changes as well as the underlying condition, helping clinicians evaluate the ongoing effects of the operation on the patient’s health.

The extent of removal determines the procedure’s reproductive and hormonal consequences. Unilateral surgery removes targeted tissue while leaving the other gonad in place, whereas bilateral surgery markedly reduces sex-hormone production and causes permanent infertility. This distinction is important when surgeons and patients consider disease control, reproductive goals, and expected long-term follow-up.

Surgical access requires management of the structures associated with the gonad, including its blood vessels and ducts. Controlling these structures allows the surgeon to separate and excise the targeted tissue through the selected operative approach. Their careful handling is therefore a central technical component of removing the gonad rather than simply cutting away the visible tissue.

The removed tissue can be submitted for pathology, which helps characterize the gonad and clarify the disease process responsible for surgery. Pathology findings complement the operative information and guide follow-up focused on the underlying condition. This assessment is especially relevant when removal was performed for a suspected or known gonadal cancer or another serious disorder.

Surgeons may reach the targeted gonad through an open operation or a minimally invasive approach. Regardless of access method, the procedure includes controlling associated vessels and ducts before excising the selected tissue. The choice of approach is part of the operative plan, while postoperative care still considers pathology, hormonal changes, fertility implications, and long-term health.

Potential indications include selected cancers, severe gonadal disorders, trauma, and gender-affirming care. The appropriate use depends on the clinical situation and the intended effect on gonadal tissue and hormone production. Because the consequences differ between unilateral and bilateral removal, evaluation also includes the patient’s reproductive goals and the follow-up needs associated with the underlying condition.

Follow-up should review the pathology results, changes in hormone production, fertility implications, and longer-term health. Bilateral removal has permanent reproductive consequences and markedly alters sex-hormone production, so these issues require particular attention. Care is also connected to the original reason for surgery, such as cancer, trauma, a severe gonadal disorder, or gender-affirming treatment.